Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0239299 POSTPARTUM CELLS DERIVED FROM PLACENTAL TISSUE, AND METHODS OF MAKING AND USING THE SAME
Cells derived from postpartum placenta and methods for their isolation are provided by the invention. The invention further provides cultures and compositions...
2017/0239298 CARDIAC PROGENITOR CELLS AND METHODS OF USE THEREFOR
Provided are pharmaceutical compositions that include a pharmaceutically acceptable carrier and isolated post-natal cardiac progenitor cells (CPCs) and/or...
2017/0239297 GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING AN IMMUNE RESPONSE-STIMULATING CYTOKINE TO ATTRACT...
A genetically modified mesenchymal stem cell (MSC) and medical use thereof in the treatment of tumors, the MSC including one or more exogenous nucleic acid...
2017/0239296 COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS
The present invention relates to compounds and compositions for expanding the number of CD34+ cells for transplantation. The invention further relates to a...
2017/0239295 CELL THERAPY COMPOSITION FOR PREVENTING OR TREATING IMMUNE DISEASE COMPRISING MESENCHYMAL STEM CELLS AND...
The present invention relates to a cell therapy composition for preventing or treating immune disease comprising mesenchymal stem cells and immunoregulatory...
2017/0239294 COMPOSITIONS AND METHODS FOR TREATING B-LYMPHOID MALIGNANCIES
Compositions and methods for inhibiting, treating, and/or preventing a B-cell neoplasm are provided.
2017/0239293 STIMULATION OF THERAPEUTIC ANGIOGENESIS BY T REGULATORY CELLS
Disclosed herein are new, useful, and non-obvious means of stimulating therapeutic angiogenesis, or conditions favorable for stimulation of therapeutic...
2017/0239292 GALLIUM-BASED GLASS COMPOSITION
A gallium silica glass composition is described. The glass can be used in variety of biomedical applications
2017/0239291 METHOD OF PREVENTING OR TREATING SINUSITIS WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION
Provided is a method for preventing or treating sinusitis by administering a therapeutically effective amount of an oxidative reduction potential (ORP) water...
2017/0239290 NEW DELIVERY VEHICLE FOR THERAPEUTIC GASES
The present invention relates to a buccal delivery dosage form and its use for administration of a therapeutic gas for buccal mucosal absorption of the...
2017/0239289 TREATMENT OF INFLAMMATION, RESPIRATORY TRACT INFECTIONS AND CYSTIC FIBROSIS
The present invention provides a method for treating a disease in a human subject in need thereof, wherein the disease is selected from the group consisting of...
2017/0239288 Positively Charged Co-Polymers for Use as Antimicrobial Agents
The present invention provides a positively charged co-polymer for use as an antimicrobial agent,wherein said positively charged co-polymer is composed of...
2017/0239287 Stabilized Glycosaminoglycan Preparations and Related Methods
Compositions comprising a glycosaminoglycan (e.g., a hyaluronan, hyaluronic acid, hyaluronate, sodium hyaluronate, dermatan sulfate, karatan sulfate,...
2017/0239286 DEVICE AND METHOD TO TREAT OR PREVENT JOINT DEGENERATION
A method for the delivery of aggrecan precursors to the joint of a subject, comprising the steps of: a) applying a composition comprising one or more aggrecan...
2017/0239285 DEVELOPMENT OF MAGNETIC-MICRO PARTICLES THAT PROVIDE CONTROLLED GLYCOSAMINOGLYCAN (GAG) RELEASE AND THE...
Disclosed is the production of Glycosaminoglycan covered with magnetic nanoparticles, with nanotechnology to be used in the repair of Glycosaminoglycan layer...
2017/0239284 ANTIBODY-SIRNA CONJUGATES AND USES THEREFOR
The disclosure provides compositions and methods relating to the treatment of pain, such as pain from rheumatoid arthritis. By creating conjugates of...
2017/0239283 USE OF STING AGONISTS TO TREAT VIRALLY-INDUCED AND PRE-MALIGNANT GROWTHS
Disclosed herein are methods of treating or inhibiting a pre-malignant condition, a benign neoplasia, or a virally-induced growth in a subject. The methods...
2017/0239282 BIDENS PILOSA AND POLYACETYLENIC COMPOUNDS FOR PREVENTION AND TREATMENT OF COCCIDIOSIS
A composition for use in prevention, inhibition and/or treatment of coccidiosis in an animal is disclosed. The composition comprises an effective amount of...
2017/0239281 COMBINATION TREATMENT OF SGLT2 INHIBITORS AND DOPAMINE AGONISTS FOR PREVENTING METABOLIC DISORDERS IN EQUINE...
The present invention relates to combination of one or more SGLT2 inhibitors or pharmaceutically acceptable forms and/or salts thereof and one or more dopamine...
2017/0239280 BICYCLIC ARYL SPHINGOSINE 1-PHOSPHATE ANALOGS
Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can...
2017/0239279 PHOSPHONATE COMPOUNDS
The present invention relates to phosphonate compounds, compositions containing them, processes for obtaining them, and their use for treating a variety of...
2017/0239278 SYSTEM AND METHOD FOR THE DETECTION AND TREATMENT OF INFECTION BY A MICROBIAL AGENT ASSOCIATED WITH HIV INFECTION
A method of treating a patient, comprising administering at least one antibiotic, e.g., doxycycline and ciprofloxacin, sufficient to substantially treat an...
2017/0239277 COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
The present application relates to compounded compositions, methods of making compounded compositions, and methods of using compounded compositions. For...
2017/0239276 PHARMACEUTICAL COMBINATIONS OF SITAGLIPTIN
A pharmaceutical combination comprising sitagliptin or a pharmaceutically acceptable salt thereof in combination with a sulfonylurea.
2017/0239275 Compositions Containing Vitamin D and Magnesium
Described herein are manufactured compositions that contain vitamin D in an amount from 3500 IU to 5000 IU and magnesium in the form of magnesium ...
2017/0239274 COMBINATION
A novel combination comprising a 17 .alpha.-hydroxylase/C17,20 lyase inhibitor, for example: (3.beta.)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol or a...
2017/0239273 COMPOSITIONS AND METHODS TO TREAT AND/OR PREVENT VISION DISORDERS OF THE LENS OF THE EYE
The disclosure generally relates to compositions and uses thereof to treat vision disorders that affect the normal function of the lens in the eye in a subject...
2017/0239272 INTRAOCULAR DRUG DELIVERY DEVICE AND ASSOCIATED METHODS
An intraocular active agent delivery device can include an active agent homogenously combined with a biodegradable active agent matrix such that the entire...
2017/0239271 DERMATOLOGICAL COMPOSITIONS AND METHODS
Dermatological compositions (methods of making and using) that include one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a...
2017/0239270 METHODS FOR TREATING CHRONIC OR UNRESOLVABLE PAIN AND/OR INCREASING THE PAIN THRESHOLD IN A SUBJECT AND...
The invention relates to a method of reducing chronic inflammatory pain in a human subject with androgen deficiency symptoms, as defined in the instant...
2017/0239269 Inhalable Formulation
This invention provides a process for preparing an inhalable active pharmaceutical ingredient comprising the steps of heating a suspension of an active...
2017/0239268 PROSTAGLANDIN CONJUGATES AND DERIVATIVES FOR TREATING GLAUCOMA AND OCULAR HYPERTENSION
Prostaglandin conjugates and derivatives and methods for their use to treat glaucoma and/or lower intraocular pressure are disclosed. Additionally, ophthalmic...
2017/0239267 CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS
Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein...
2017/0239266 PHARMACEUTICAL COMPOSITIONS FOR INHIBITING ANGIOGENESIS COMPRISING PLANT-DERIVED NATURAL COMPOUND
The present invention provides a pharmaceutical composition for inhibiting angiogenesis containing a plant-derived natural compound which can be effective for...
2017/0239265 DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE
An object of the present invention is to provide a combination drug that has remarkably excellent preventive and/or therapeutic effects on polycystic kidney...
2017/0239264 AMINOPYRIMIDINYL COMPOUNDS
A compound having the structure: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein X is N or CR, where R is hydrogen, deuterium,...
2017/0239263 METHOD OF WEIGHT MANAGEMENT
Provided are methods of determining if an individual is a responder to treatment with (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine or a...
2017/0239262 CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
The present disclosure provides methods of treating fibrosis or a fibrotic disease or condition in a subject in need thereof comprising administering to the...
2017/0239261 EPIDITHIODIOXOPIPERAZINE COMPOUND OR ITS DERIVATIVES, AND THE USE THEREOF
The present invention relates to an epidithiodioxopiperazine derivative represented by the following Chemical Formula 1 or its reduced derivative; a method for...
2017/0239260 METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL
The present disclosure in various embodiments teaches methods of treating patients in need of treatment with a Factor Xa inhibitor, and who are also...
2017/0239259 ARYLOXY PHENOXY ACRYLIC COMPOUND HAVING HIF-1 INHIBITION ACTIVITY, METHOD FOR PREPARING SAME, AND...
The present invention relates to a compound inhibiting HF-1 activity, a preparation method of the same, and a pharmaceutical composition comprising the same as...
2017/0239258 MATERIALS AND METHODS FOR TARGETING THERAPEUTIC COMPOSITIONS TO GUT-ASSOCIATED LYMPHOID TISSUE (GALT)
The present invention provides novel, long-acting nanoformulated drugs and targeted drug delivery methods, and uses thereof. In one embodiment, the...
2017/0239257 Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and...
The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis,...
2017/0239256 CRYSTALLINE Pl3 KINASE INHIBITORS
There is provided inter alia 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl) methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-di...
2017/0239255 Combination
The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular, the method...
2017/0239254 DEUTERATED DERIVATIVES OF RUXOLITINIB
The present invention in one embodiment provides a compound of Formula A: ##STR00001## or a pharmaceutically acceptable salt thereof; pharmaceutical compositions...
2017/0239253 COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Methods useful for sustaining a reduction of non-alcoholic steatohepatitis are provided herein. Such methods may comprise administering to a subject in need...
2017/0239252 SUSTAINED RELEASE SMALL MOLECULE DRUG FORMULATION
An injectable depot formulation includes a biocompatible polymer, an organic solvent combined with the biocompatible polymer to form a viscous gel, and a small...
2017/0239251 (AZA)PYRIDOPYRAZOLOPYRIMIDINONES AND INDAZOLOPYRIMIDINONES AND THEIR USE
The present application relates to novel substituted (aza)pyridopyrazolopyrimidinones and indazolopyrimidinones, to processes for their preparation, the...
2017/0239250 PEMETREXED FORMULATIONS
The present invention is directed to pemetrexed formulations comprising a non-aqueous solvent that remains stable after dilution for at least about 48 hours...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.